NCT01203085 Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT Status COMPLETED Phase N/A
NCT01193088 Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 Status RECRUITING Phase N/A
NCT01193075 Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Status RECRUITING Phase N/A
NCT01125709 Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS) Status COMPLETED Phase N/A
NCT01083667 SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE1/PHASE2
NCT01041222 Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations Status COMPLETED Phase PHASE1
NCT00983983 High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT00790582 A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT00577577 Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1 Status COMPLETED Phase PHASE2
NCT00494195 Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) Status COMPLETED Phase PHASE1
NCT00457912 Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy Status COMPLETED Phase N/A
NCT00302198 Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org Status COMPLETED Phase N/A
NCT00264888 Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE2
NCT00107770 Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) Status COMPLETED Phase PHASE1/PHASE2
NCT00005674 Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] Status COMPLETED Phase PHASE2